Detalhe da pesquisa
1.
[Enhancement of Antitumor Effect by the Combined Use of Anti-EGFR Antibody(Necitumumab)and PD-1 Inhibitor].
Gan To Kagaku Ryoho
; 50(12): 1307-1310, 2023 Dec.
Artigo
Japonês
| MEDLINE | ID: mdl-38247069
2.
Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster.
J Virol
; 86(21): 11558-66, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22896607
3.
Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity.
Mol Cancer Ther
; 19(4): 988-998, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32241872
4.
Role of the N- and C-lobes of calmodulin in the activation of Ca(2+)/calmodulin-dependent protein kinase II.
Biochemistry
; 47(40): 10587-99, 2008 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-18795794
5.
Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance.
Mol Cancer Ther
; 17(2): 521-531, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29158469
6.
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054.
J Immunother Cancer
; 6(1): 45, 2018 06 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29866166
7.
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054.
J Immunother Cancer
; 6(1): 31, 2018 04 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29712568
8.
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade.
Cell Rep
; 22(11): 2978-2994, 2018 03 13.
Artigo
Inglês
| MEDLINE | ID: mdl-29539425
9.
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Thorac Oncol
; 12(2): 383-389, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27464970
10.
Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations.
Clin Cancer Res
; 23(18): 5547-5560, 2017 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28611205
11.
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy.
Clin Cancer Res
; 22(2): 301-9, 2016 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26324738
12.
Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor.
Mol Cancer Res
; 13(12): 1615-26, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26263910
13.
A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation.
MAbs
; 7(5): 931-45, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26073904
14.
Structure and composition of the postsynaptic density during development.
J Comp Neurol
; 518(20): 4243-60, 2010 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20878786